Skip to content
PeptideFactSheets
Not FDA approvedLimited or unclear evidence

Amino sulfonic acid fact sheet

Taurine

Also known as 2-aminoethanesulfonic acid

Healthy agingMuscle and performanceHeart and vascularMetabolic health

Taurine is important in normal physiology and extended lifespan in some animal experiments. Human and longitudinal evidence challenges the idea that falling taurine is a universal driver of aging.

Quick answer

Taurine is not an FDA-approved anti-aging treatment. A major animal study sparked longevity interest, but later human and cross-species studies did not confirm circulating taurine as a reliable aging biomarker or deficiency as a universal human aging driver.

By the PeptideFactSheets Editorial Team. Use the source links to verify status, evidence, risks, and unknowns; our editorial policyexplains the boundaries. Clinician review appears only when a named reviewer is shown.

What is Taurine?

Taurine is an amino sulfonic acid present in many tissues and involved in bile acids, cell-volume regulation, calcium signaling, and nervous-system and muscle biology.

It is not incorporated into proteins like a standard amino acid, and blood concentration may not directly represent tissue status or treatment need.

Why are people interested in it?

A prominent Science study reported lower taurine with age in selected data and longer lifespan in treated mice and worms.

Subsequent human cohorts and direct physiology work found stable or increasing levels with age and no consistent link to strength or mitochondrial function.

Current regulatory status

Not FDA approved

No taurine drug is FDA approved to slow aging, extend lifespan, prevent frailty, or improve general performance. Supplement marketing does not equal FDA-reviewed effectiveness.

What is it approved for?

No FDA-approved use. Commercial availability, supplement marketing, and clinical research do not equal an FDA-approved medicine.

FDA approval path

No active FDA drug path

No FDA-approved anti-aging drug use

Taurine is a normal nutrient-related molecule with animal and observational aging research, but no FDA-approved drug use for lifespan, frailty, or general performance.

  1. DiscoveryBasic research
  2. PreclinicalLab and animal work
  3. Phase 1Initial human testing
  4. Phase 2Condition-focused trials
  5. Phase 3Confirmatory trials
  6. FDA reviewApplication review
  7. ApprovedLabel-specific use

This status sits outside the standard stepwise FDA drug-approval path.

Timeline source basis

Taurine deficiency as a driver of agingLongitudinal challenge to taurine as an aging biomarkerFDA: dietary supplements are not preapproved for effectiveness

What is it being studied for?

Animal lifespan and healthspan
Human aging biomarkers
Muscle and mitochondrial function
Cardiometabolic outcomes

Evidence snapshot

Limited or unclear evidence

Animal intervention evidence is provocative, while human evidence is observational, inconsistent, and increasingly contradictory. No human longevity trial establishes benefit.

Potential benefits being researched

  • Animal experiments reported improved health measures and lifespan in selected species.
  • Human associations do not establish benefit, and other studies directly challenge the claimed age-related deficiency pattern.

A mechanism, biomarker, or secondary endpoint is not proof of a meaningful clinical benefit.

Known or possible risks

  • Supplement trials are not large or long enough to define every uncommon harm or interaction.
  • A normal or altered blood level does not automatically identify a deficiency that should be corrected.
  • Commercial combination products can add ingredients and risks unrelated to taurine itself.

What we still do not know

  • Whether taurine improves any validated human aging outcome
  • Which tissue measures, if any, reflect a clinically meaningful deficiency
  • Whether animal lifespan effects translate to people
  • Long-term effects in diverse populations

Plain-English takeaway

Taurine is biologically important, but the simple story that taurine deficiency drives human aging has not held up cleanly. Human longevity benefit is unproven.

Research and reference links

Use these primary and authoritative sources to verify status and read beyond this summary. A study or registry entry does not by itself prove benefit.

  1. 1
    pubmedTaurine deficiency as a driver of aging

    Influential multi-species study with animal intervention and human association components.

  2. 2
    pubmedLongitudinal challenge to taurine as an aging biomarker

    Human and cross-species data finding stable or increasing circulating taurine with age.

  3. 3
    pubmedHuman evidence against taurine deficiency as an aging driver

    Human physiology study finding no association with age, strength, performance, or mitochondrial function.

  4. 4
    fdaFDA: dietary supplements are not preapproved for effectiveness

    FDA explanation of the regulatory distinction between approved drugs and marketed dietary supplements.